← All indications
Tremor
Cyclical movement of a body part that can represent either a physiologic process or a manifestation of disease. Intention or action tremor, a common manifestation of CEREBELLAR DISEASES, is aggravated by movement. In contrast, resting tremor is maximal when there is no attempt at voluntary movement, and occurs as a relatively frequent manifestation of PARKINSON DISEASE.
Drugs by status
Approved for this indication (1)
Phase 4 trials (5)
Phase 3 trials (3)
Phase 1 trials (1)
Other trials (1)
Organizations
Organization Involved with Phase 4 Indications (10)
Organization Involved with Phase 3 Indications (12)
- Allergan
- Veloxis Pharmaceuticals
- National Institute on Deafness and Other Communication Disorders (NIDCD)
- Massachusetts Eye and Ear Infirmary
- Harvard University
- Melbourne Health
- University of Pecs
- University of Ulsan
- Eastern Health, Canada
- University of Montreal
- Johnson and Johnson
- University Clermont Auvergne
Organization Involved with Phase 2 Indications (21)
- Jazz Pharmaceuticals
- Cavion LLC
- Merz
- Sage Therapeutics
- Arvelle
- Sonexa Therapeutics, Inc.
- Tilray
- National Institute of Neurological Disorders and Stroke (NINDS)
- Yale University
- Syracuse University
- University of California, Davis
- University of California, San Diego
- University of Colorado, Denver
- GW Research
- Taro Pharmaceuticals
- Rush University
- Quest Research Institute
- University of Western Ontario
- Colorado Department of Public Health and Environment
- Cadent Therapeutics
- international essential tremor foundation
Organization Involved with Phase 1 Indications (1)
Organization Involved with Other Experimental Indications (6)